In parallel, it has also shown possible benefits in a variety of neurological conditions, including mild cognitive impairment, cyclin-dependent kinase-like 5 (CDKL5) deficiency, pyruvate dehydrogenase complex deficiency, Alzheimer’s and Parkinson’s disease [38,39,40,41,42], and many more, gaining immense popularity. This evidence concerns the gene CDKL5 and Parkinson disease.